Fusion-independent virus-like particles enable rapid detection of antibody-mediated inhibition of ligand-receptor interactions
- 1Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology
Abstract
Studying antibody-mediated inhibition of ligand-receptor interactions is critical for understanding fundamental biological processes and developing therapeutic interventions. However, for high-consequence viruses with entry machinery involving multiple viral proteins, it is often difficult to develop pseudotyped viruses that can infect susceptible host cells. Here, we report a rapid platform for detecting antibody-mediated inhibition of ligand-receptor interactions by decoupling viral attachment from post-entry membrane fusion and gene expression. Our platform leverages HIV Gag-based self-assembling virus-like particles (VLPs) where Gag is fused with GFP and further pseudotyped with selected ligands for easy readout of VLP binding to susceptible cells. We first validated the platform’s stringent cell-type specificity using broadly tropic VSV-G and CD19-specific single chain fragment variable (scFv) pseudotypes. Next, we applied this technology to African swine fever virus (ASFV) - a high-consequence agricultural pathogen lacking surrogate neutralization assays due to its multi-protein entry machinery. By screening VLPs pseudotyped with different viral proteins against diverse mammalian cell lines, we found that VLP pseudotyped with ASFV CD2v binds specifically to Vero cells. Leveraging this interaction, we developed a rapid test for detecting antibodies that inhibit CD2v-pseudotyped VLP binding to Vero cells. Longitudinal analysis of sera from mRNA-LNP vaccinated pigs showed that the degrees of VLP-based binding-inhibition strongly correlated with the levels of anti-CD2v IgG, validating the assay’s utility. Overall, the pseudotyped VLP platform provides an enabling tool for ligand-receptor discovery, vaccine evaluation, and disease surveillance for select agents.
Related
- Tc17-driven antibody-independent mucosal immunity is critical for protection against extracellular bacterial pneumonia
- Insight into the mechanism of molecular interactions of the NDM metallo-beta-lactamase and cyclic boronate inhibition by molecular docking and molecular dynamics simulations
- Notch-independent Her6 contributes to control of neural stem cell maintenance by shifting Notch signaling from lateral inhibition towards lateral induction mode
- Impaired T cell-Independent antibody responses and mucosal IgA production in Traf5-deficient mice
- Heterologous expression of the membrane protein OmpA from bovine Pasteurella multocida and establishment of an indirect ELISA for antibody detection
BibTeX
@article{yuan2026fusionindependent,
title = {{Fusion-independent virus-like particles enable rapid detection of antibody-mediated inhibition of ligand-receptor interactions}},
author = {Fangfeng Yuan and Jianzhu Chen},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1943580},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1943580/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Fusion-independent virus-like particles enable rapid detection of antibody-mediated inhibition of ligand-receptor interactions
AU - Fangfeng Yuan
AU - Jianzhu Chen
PY - 2026
DA - 2026/10/28
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1943580
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1943580/full
AB - Studying antibody-mediated inhibition of ligand-receptor interactions is critical for understanding fundamental biological processes and developing therapeutic interventions. However, for high-consequence viruses with entry machinery involving multiple viral proteins, it is often difficult to develop pseudotyped viruses that can infect susceptible host cells. Here, we report a rapid platform for detecting antibody-mediated inhibition of ligand-receptor interactions by decoupling viral attachment from post-entry membrane fusion and gene expression. Our platform leverages HIV Gag-based self-assembling virus-like particles (VLPs) where Gag is fused with GFP and further pseudotyped with selected ligands for easy readout of VLP binding to susceptible cells. We first validated the platform’s stringent cell-type specificity using broadly tropic VSV-G and CD19-specific single chain fragment variable (scFv) pseudotypes. Next, we applied this technology to African swine fever virus (ASFV) - a high-consequence agricultural pathogen lacking surrogate neutralization assays due to its multi-protein entry machinery. By screening VLPs pseudotyped with different viral proteins against diverse mammalian cell lines, we found that VLP pseudotyped with ASFV CD2v binds specifically to Vero cells. Leveraging this interaction, we developed a rapid test for detecting antibodies that inhibit CD2v-pseudotyped VLP binding to Vero cells. Longitudinal analysis of sera from mRNA-LNP vaccinated pigs showed that the degrees of VLP-based binding-inhibition strongly correlated with the levels of anti-CD2v IgG, validating the assay’s utility. Overall, the pseudotyped VLP platform provides an enabling tool for ligand-receptor discovery, vaccine evaluation, and disease surveillance for select agents.
SN - 1664-3224
ER -